The global chromatography market is projected to grow from USD 10.03 billion in 2025 to USD 13.69 billion by 2031 at a CAGR of 5.32%, driven by expanding R&D in pharma/biotech and strict food safety regulations. However, high capital costs limit adoption among smaller entities. Emerging trends include green chromatography and AI-powered method optimization.

The global microarrays market is projected to grow from USD 6.16 billion in 2025 to USD 10.72 billion by 2033, at a CAGR of 7.24%. Growth is driven by increasing adoption of genomics and proteomics research, drug discovery applications, and disease diagnostics. North America dominates with 43% market share, while Asia Pacific emerges as the fastest-growing region with a 9.54% CAGR.

The global next-generation sequencing (NGS) market is expected to grow from USD 14.25 billion in 2025 to USD 103.24 billion by 2035, at a CAGR of 21.9%. North America currently dominates with 50% market share, while Asia Pacific is the fastest-growing region. Oncology is the leading application segment, and consumables represent the largest product category. Key industry players are advancing NGS technology through strategic partnerships and innovative platforms.

German life sciences company Qiagen is exploring strategic options including a potential sale, with renewed takeover interest from multiple U.S.-based strategic buyers. The company has engaged advisers as its supervisory board evaluates preliminary approaches. CEO Thierry Bernard's announced departure is seen as removing a key obstacle to a deal. Qiagen has attracted acquisition interest multiple times in recent years, including failed attempts from Thermo Fisher Scientific (2020, ~$12 billion), BioMérieux (2021), and Bio-Rad Laboratories (2022).

The global antibody optimization service market is projected to grow from USD 1.36 billion in 2024 to USD 2.87 billion by 2033, with a CAGR of 8.81%. Growth is driven by rising prevalence of complex diseases, increased R&D investments in biologics, and advancements in computational modeling and protein engineering technologies.

The global custom antibody market is projected to grow from USD 608.75 million in 2025 to USD 1,297.65 million by 2033, at a CAGR of 9.98%. Growth is driven by increasing demand for precision medicine, targeted therapies, advancements in antibody engineering, and rising investments in biopharmaceutical R&D. However, high development costs and technical challenges may hinder market expansion.

The global autism spectrum disorder diagnostics market is projected to grow from $27.38 billion in 2024 to $43.36 billion by 2034, with a CAGR of 4.7%. Key growth drivers include increasing healthcare expenditure, R&D investments, and government initiatives. The autistic disorder segment will dominate at 52.82% market share, while early intervention services and online pharmacies emerge as fastest-growing segments. Major players include LabCorp, Illumina, and Bio-Rad Laboratories, with Asia Pacific and Western Europe expected to lead regional growth.

The global IVD diagnostic molecule raw enzymes market is projected to grow from USD 2.39 billion in 2024 to USD 4.73 billion by 2034, with a 7.13% CAGR. Key growth drivers include increasing chronic diseases, technological advancements in molecular diagnostics, and rising demand for precision medicine.

Global blood group typing market expected to grow from $2.4 billion in 2024 to $3.9 billion by 2030, driven by advancements in molecular technologies, increasing surgeries, and healthcare infrastructure expansion in emerging economies.

AppLovin, an adtech company, was added to the S&P 500 in September 2025 after significant growth driven by its Axon 2.0 AI software. While S&P 500 inclusion doesn't guarantee future performance, the company shows promising growth potential by expanding beyond mobile gaming into e-commerce and connected TV advertising.

Bio-Rad Laboratories reported Q3 earnings with modest revenue growth of 0.5% and beat analyst estimates, but investors reacted negatively due to low growth rates and challenges in biotech funding and academic research.

The global human combinatorial antibody libraries market is projected to grow from USD 122 million in 2025 to USD 189.57 million by 2034, with a 5.04% CAGR, driven by increasing demand for advanced medical technologies and therapeutic antibody research.